This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (45)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neonatology and Infant Care  • Psychiatry  • Pregnancy and Breast Feeding  • Alert me on articles by topic  Social Bookmarking   What's this?

Bengt Källén, MD, PhD

Arch Pediatr Adolesc Med. 2004;158:312-316.

Background  Exposure to antidepressants during the third trimester of pregnancy has been associated with an increased risk for adverse birth outcomes, including preterm birth, respiratory distress, and hypoglycemia.

Objective  To investigate neonatal outcomes in 997 infants (987 mothers) after maternal use of antidepressants based on prospectively recorded information in antenatal care documents.

Results  An increased risk for preterm birth (odds ratio [OR], 1.96) and low birth weight (OR, 1.98) was verified, but the gestational week-specific birth weight was increased notably after exposure to tricyclic antidepressants. An increased risk for a low Apgar score (OR, 2.33), respiratory distress (OR, 2.21), neonatal convulsions (OR,1.90), and hypoglycemia (OR, 1.62) was found, the latter especially after exposure to tricyclic drugs, but no significant effect on the frequency of neonatal jaundice was seen (OR, 1.13). Most effects seemed not to be selective serotonin reuptake inhibitor drug specific, and outcomes after exposure to paroxetine hydrochloride were not worse than after exposure to other selective serotonin reuptake inhibitors.

Conclusions  Neonatal effects after maternal use of antidepressant drugs during late pregnancy were seen. Selective serotonin reuptake inhibitors may be the drugs of choice during pregnancy.

From the Tornblad Institute, University of Lund, Lund, Sweden.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Discontinuation Syndrome Following Late Pregnancy Exposure to Antidepressants
Gideon Koren
Arch Pediatr Adolesc Med. 2004;158(4):307-308.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Selective Serotonin Reuptake Inhibitor Exposure In Utero and Pregnancy Outcomes
Lund et al.
Arch Pediatr Adolesc Med 2009;163:949-954.
ABSTRACT | FULL TEXT  

Major Depression and Antidepressant Treatment: Impact on Pregnancy and Neonatal Outcomes
Wisner et al.
Focus 2009;7:374-384.
ABSTRACT | FULL TEXT  

Clinical Management Guidelines for Obstetrician-Gynecologists Use of Psychiatric Medications During Pregnancy and Lactation
ACOG Practice Bulletin
Focus 2009;7:385-400.
ABSTRACT | FULL TEXT  

Major Depression and Antidepressant Treatment: Impact on Pregnancy and Neonatal Outcomes
Wisner et al.
Am. J. Psychiatry 2009;166:557-566.
ABSTRACT | FULL TEXT  

Selective Serotonin Reuptake Inhibitor Use and Risk of Gestational Hypertension
Toh et al.
Am. J. Psychiatry 2009;166:320-328.
ABSTRACT | FULL TEXT  

Antenatal Use of Selective Serotonin-Reuptake Inhibitors and QT Interval Prolongation in Newborns
Dubnov-Raz et al.
Pediatrics 2008;122:e710-e715.
ABSTRACT | FULL TEXT  

Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study
Oberlander et al.
Br. J. Psychiatry 2008;192:338-343.
ABSTRACT | FULL TEXT  

Effects of Antenatal Depression and Antidepressant Treatment on Gestational Age at Birth and Risk of Preterm Birth
Suri et al.
Am. J. Psychiatry 2007;164:1206-1213.
ABSTRACT | FULL TEXT  

Safety of selective serotonin reuptake inhibitors in pregnancy
Donnelly and Paton
Psychiatr. Bull. 2007;31:183-186.
ABSTRACT | FULL TEXT  

Potential Medical and Surgical Complications of Serotonergic Antidepressant Medications
Looper
Psychosomatics 2007;48:1-9.
ABSTRACT | FULL TEXT  

Effects of Selective Serotonin Reuptake Inhibitors and Venlafaxine During Pregnancy in Term and Preterm Neonates
Ferreira et al.
Pediatrics 2007;119:52-59.
ABSTRACT | FULL TEXT  

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
Oberlander et al.
Arch Gen Psychiatry 2006;63:898-906.
ABSTRACT | FULL TEXT  

Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
Chambers et al.
NEJM 2006;354:579-587.
ABSTRACT | FULL TEXT  

Depressing Observations on the Use of Selective Serotonin-Reuptake Inhibitors during Pregnancy
Mills
NEJM 2006;354:636-638.
FULL TEXT  

Neonatal Abstinence Syndrome After In Utero Exposure to Selective Serotonin Reuptake Inhibitors in Term Infants
Levinson-Castiel et al.
Arch Pediatr Adolesc Med 2006;160:173-176.
ABSTRACT | FULL TEXT  

Prolonged QT interval in an infant of a fluoxetine treated mother
Dubnov et al.
Arch. Dis. Child. 2005;90:972-973.
ABSTRACT | FULL TEXT  

Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?
Koren et al.
CMAJ 2005;172:1457-1459.
FULL TEXT  

Neonatal Signs After Late In Utero Exposure to Serotonin Reuptake Inhibitors: Literature Review and Implications for Clinical Applications
Moses-Kolko et al.
JAMA 2005;293:2372-2383.
ABSTRACT | FULL TEXT  

Journal Watch
Arch. Dis. Child. 2004;89:888-889.
FULL TEXT  

Antidepressant Use in Late Pregnancy: Neonatal Outcomes
JWatch Psychiatry 2004;2004:9-9.
FULL TEXT  

Antidepressant Use in Late Pregnancy: Neonatal Outcomes
JWatch General 2004;2004:7-7.
FULL TEXT  

Discontinuation Syndrome Following Late Pregnancy Exposure to Antidepressants
Koren
Arch Pediatr Adolesc Med 2004;158:307-308.
FULL TEXT